StockData
Medline Inc. logo

Medline Inc.

MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3068% above fair value
$37.84−1.32 (-3.37%)

Close on Nov 19, 2026Market cap $49.75BP/E –Yield –

Medline Trailing-Twelve-Month Adjusted EBITDA by Quarter

Trailing-Twelve-Month Adjusted EBITDA ($M)

Medline Trailing-Twelve-Month Adjusted EBITDA: $3,601M in Q3 2026.

Latest, Q3 2026
3,601
Period ended Sep 30, 2026
Change on a year earlier
–
History
5 quarters
Since Q4 2024
Sources
4
Documents cited below

Where the Q3 2026 figure comes from

Source: SEC Form 8-K Ex. 99.1 Q3 2026 Earnings Release (2026-11-04) ↗

Reported in SEC Form 8-K Earnings Releases.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Medline Trailing-Twelve-Month Adjusted EBITDA ($M), quarterly Q4 2024–Q3 2026 [Data set]. Compiled from Medline SEC filings and investor materials. https://stockdatahq.com/stocks/mdln/kpis/cap-ttm-adj-ebitda

See every metric in the Medline KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?